U.S. markets close in 22 minutes
  • S&P 500

    4,391.61
    -30.69 (-0.69%)
     
  • Dow 30

    34,994.97
    -149.34 (-0.42%)
     
  • Nasdaq

    14,630.36
    -210.36 (-1.42%)
     
  • Russell 2000

    2,186.42
    -30.50 (-1.38%)
     
  • Crude Oil

    71.67
    -0.24 (-0.33%)
     
  • Gold

    1,799.60
    +0.40 (+0.02%)
     
  • Silver

    24.76
    -0.56 (-2.20%)
     
  • EUR/USD

    1.1823
    +0.0015 (+0.13%)
     
  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     
  • GBP/USD

    1.3879
    +0.0055 (+0.40%)
     
  • USD/JPY

    109.7390
    -0.6360 (-0.58%)
     
  • BTC-USD

    38,103.36
    -1,984.81 (-4.95%)
     
  • CMC Crypto 200

    900.77
    +24.54 (+2.80%)
     
  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     
  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

Arena Pharmaceuticals Earnings Preview

·2 min read

On Tuesday, February 23, Arena Pharmaceuticals (NASDAQ:ARNA) will release its latest earnings report. Check out Benzinga's preview to understand the implications.

Net Income, Earnings, And Earnings Per Share

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Based on Arena Pharmaceuticals management projections, analysts predict EPS of $1.85 on revenue of $560.00 thousand. In the same quarter last year, Arena Pharmaceuticals posted EPS of $1.76 on sales of $3.00 million.

Why Analyst Estimates And Earnings Surprises Are Important

Wall Street analysts who study this company will publish analyst estimates of revenue and EPS. The averages of all analyst EPS and revenue estimates are called the "consensus estimates"; these consensus estimates can have a significant effect on a company's performance during an earnings release. When a company posts earnings or revenue above or below a consensus estimate, it has posted an "earnings surprise", which can really move a stock depending on the difference between actual and estimated values.

View more earnings on ARNA

The Wall Street estimate would represent a 5.11% decline in the company's earnings. Sales would be down 81.35% on a year-over-year basis. Here is how the company's reported EPS has stacked up against analyst estimates in the past:

EPS Estimate

-1.87

-2.03

-2.28

-1.55

EPS Actual

-1.69

-1.61

-2

-1.76

Revenue Estimate

1.23 M

1.47 M

1.58 M

1.74 M

Revenue Actual

20.00 K

0

262.00 K

3.00 M

Stock Performance

Over the last 52-week period, shares are up 69.47%. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Do not be surprised to see the stock move on comments made during its conference call. Arena Pharmaceuticals is scheduled to hold the call at 16:30:00 ET and can be accessed here.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.